Top

Published in:

01-03-2005 | Review

Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease

Authors: Z. A. Massy, C. Mazière, S. Kamel, M. Brazier, G. Choukroun, C. Tribouilloy, M. Slama, M. Andrejak, J. C. Mazière

Published in: Pediatric Nephrology | Issue 3/2005

Abstract

Vascular and/or valvular calcifications in patients with chronic kidney disease (CKD) appear to indicate a poor prognosis in terms of overall survival and cardiovascular morbidity and mortality. Inflammation and oxidative stress represent new features of the arterial and/or valvular calcification process. However, only limited observational and epidemiological data are available in these areas. Therefore, the link between inflammation, oxidation and vascular and/or valvular calcifications deserves careful consideration in CKD patients, since they may become targets for the development of new therapeutic strategies.

Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147CrossRefPubMed

Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H (2000) Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343:611–617CrossRefPubMed

Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K (2003) Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107:2571–2576CrossRefPubMed

Iribarren C, Sidney S, Sternfeld B, Browner WS (2000) Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 283:2810–2815CrossRefPubMed

Li J, Galvin HK, Johnson SC, Langston CS, Sclamberg J, Preston CA (2002) Aortic calcification on plain chest radiography increases risk for coronary artery disease. Chest 121:1468–1471CrossRefPubMed

Wilson PW, Kauppila LI, O’Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA (2001) Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103:1529–1534PubMed

Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29:630–634CrossRefPubMed

Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401PubMed

Perkovic V, Hunt D, Griffin SV, Plessis M du, Becker GJ (2003) Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Pract 94:c40–c45CrossRefPubMed

10.

Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936PubMed

11.

Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942PubMed

12.

London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731–1740CrossRefPubMed

13.

Kaysen GA (2001) The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12:1549–1557PubMed

14.

Massy Z, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: markers and management. J Nephrol 15:336–341PubMed

15.

Schinke T, Karsenty G (2000) Vascular calcification—a passive process in need of inhibitors. Nephrol Dial Transplant 15:1272–1274CrossRefPubMed

16.

Tomson C (2003) Vascular calcification in chronic renal failure. Nephron Clin Pract 93:c124–c130CrossRefPubMed

17.

Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38 [Suppl 1]:S34–S37

18.

Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680–687PubMed

19.

Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636–2642PubMed

20.

Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10–E17PubMed

21.

Chen NX, O’Neill KD, Duan D, Moe SM (2002) Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62:1724–1731CrossRefPubMed

22.

Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519CrossRefPubMed

23.

Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H (1999) Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun 258:353–357CrossRefPubMed

24.

Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL (2002) High-density lipoprotein regulates calcification of vascular cells. Circ Res 91:570–576CrossRefPubMed

25.

Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL (2002) Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105:650–655CrossRefPubMed

26.

Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9–16CrossRefPubMed

27.

Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366CrossRefPubMed

28.

Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105CrossRefPubMed

29.

Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203–211CrossRefPubMed

30.

Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, Clouse ME, D’Agostino RB, Wilson PW, O’Donnell CJ (2002) C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 106:1189–1191CrossRefPubMed

31.

Redberg RF, Rifai N, Gee L, Ridker PM (2000) Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol 36:39–43CrossRefPubMed

32.

Park R, Detrano R, Xiang M, Fu P, Ibrahim Y, LaBree L, Azen S (2002) Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106:2073–2077CrossRefPubMed

33.

Hunt ME, O’Malley PG, Vernalis MN, Feuerstein IM, Taylor AJ (2001) C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 141:206–210CrossRefPubMed

34.

Reilly MP, Wolfe ML, Localio AR, Rader DJ; Study of Inherited Risk of Coronary Atherosclerosis (2003) C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 23:1851–1856CrossRefPubMed

35.

Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827–833CrossRefPubMed

36.

Ohnishi T, Nakamura O, Arakaki N, Miyazaki H, Daikuhara Y (1994) Effects of cytokines and growth factors on phosphorylated fetuin biosynthesis by adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 200:598–605CrossRefPubMed

37.

Sakata N, Noma A, Yamamoto Y, Okamoto K, Meng J, Takebayashi S, Nagai R, Horiuchi S (2003) Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant 18:1601–1609CrossRefPubMed

Title: Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease
Authors: Z. A. Massy
C. Mazière
S. Kamel
M. Brazier
G. Choukroun
C. Tribouilloy
M. Slama
M. Andrejak
J. C. Mazière
Publication date: 01-03-2005
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 3/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-004-1623-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2005

Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry

Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure

Identification of the first patient with a confirmed mutation of the JAK-STAT system

Functional consequences of IGFBP excess—lessons from transgenic mice

Genetic regulation of bone mass: from bone density to bone strength

Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance